✦ LIBER ✦

Phase 2B Randomized Trial Comparing Concurrent Chemoradiation to 6 Fractions/Week Accelerated Radiation Therapy in Advanced Squamous Cell Carcinomas of Head and Neck

✍ Scribed by Kainickal, C.T.; Erakotan, G.K.; Kumar, R.R.; Sudha, A.S.; Rafi, M.; Ramadas, K.

Book ID: 122203884
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 45 KB
Volume: 87
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2013.06.1261

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent Chemoradiation (CCR) Takes an

Concurrent Chemoradiation (CCR) Takes an Advantage Over Accelerated Radiation Therapy Alone (ARA) in Patients With Moderate Advanced Head-and-Neck Squamous Cell Carcinoma (MAHNSCC): Early Results of Phase 3 Polish HN08 Trial

✍ Skladowski, K.; Wygoda, A.; Snietura, M.; Heyda, A.; Rutkowski, T.; Hutnik, M.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Hyperfractionated radiation therapy with

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ B Jeremic; Y Shibamoto; B Milicic; N Nikolic; A Dagovic; J Aleksandrovic; Z Vask 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 12 KB

Mature results of a Phase III randomized

Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck

✍ David J. Adelstein; Pierre Lavertu; Jerrold P. Saxton; Michelle Secic; Benjamin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 3 views

The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.

Mature results of a phase III randomized

Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck

✍ D.J Adelstein; P Lavertu; J.P Saxton; M Secic; B.G Wood; J.R Wanamaker; I Eliach 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 11 KB

Quality-adjusted survival analysis of Ra

Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: Phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma

✍ Andre A. Konski; Kathryn Winter; Bernard F. Cole; Kie-Kian Ang; Karen K. Fu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Abstract ## Background. To evaluate quality‐adjusted survival (QAS) of patients with locally advanced squamous cell carcinoma of the head and neck treated with 4 different radiation fractionation schedules. ## Methods. QAS was calculated using the quality‐adjusted time without toxicity or rel

Radiation therapy alone or with concurre

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ Branislav Jeremic; Yuta Shibamoto; Bozidar Stanisavljevic; Ljubisa Milojevic; Bi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 986 KB